CooperCompanies Q2 rev up 15% to $829.8M; GAAP EPS $2.55, adj EPS $3.24

COOPER COMPANIES, INC.

2022-Q2 EPS reported $4.45 revenue$1,616,900,000

CooperVision revenue $553.8M (+6% reported, +12% organic); toric and multifocal sales strong.
CooperSurgical revenue $276.0M (+40% reported, +6% organic); fertility segment organic growth 15%.
FY2022 guidance: revenue $3.28-3.312B, non-GAAP diluted EPS $13.09-13.29, reflecting FX headwinds.
Exited contact lens solutions business in April; closed SightGlass JV with EssilorLuxottica in March.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.